Key Developments For China Sky One Medical, Inc.
China Sky One Medical, Inc. (CSKI.O) (Consolidated Issue listed on NASDAQ Global Market)
China Sky One Medical, Inc. Reaffirms FY 2009 Guidance
China Sky One Medical, Inc. reiterated its fiscal 2009 guidance and expects revenue to increase by 40%, or approximately $37.0 million, to $130 million, driven by growth in all of product sales categories and net income to increase approximately $39 million.
China Sky One Medical, Inc. Submits Application To Perform Clinical Trials For Two New Eye Drugs To SFDA
China Sky One Medical, Inc. announced that it has finished the required research for two new generic drugs for eye treatment and submitted application to the State Food and Drug Administration (SFDA) in China to perform clinical trials.
China Sky One Medical, Inc. Reiterates FY 2009 Guidance
China Sky One Medical, Inc. reiterated its fiscal 2009 guidance and expects revenue to increase by 40%, or approximately $37.0 million, to $128-$130 million, driven by growth in all of product sales categories and net income to increase to $38-$39 million.
China Sky One Medical, Inc. Obtains Production License Renewal for Sumei Slim Patch
China Sky One Medical, Inc. announced that it obtained a renewal of its license for the production its Sumei Slim Patch from Heilongjiang Provincial FDA, which will be effective through April of 2013. Categorized as a medical device, the document number for the renewed SFDA approval of the Sumei Slim Patch is 2640029.
China Sky One Medical, Inc. Obtains SFDA Approval For Diclofenac Sodium Eye Drops
China Sky One Medical, Inc. announced that it obtained approval from the State Food and Drug Administration (SFDA) in China for the production of Diclofenac Sodium eye drops. The document number for the drug is 2009S02063. Diclofenac Sodium eye drops are used to treat uveitis, keratitis and sclerotitis, conditions that affect the eye. They are able to inhibit new formations of unwanted vessels in the cornea and to reduce inflammation after various types of eye operations, such as laser treatment, cataract surgery and intraocular lens operations. Diclofenac Sodium eye drops also help cure seasonal conjunctivitis and allergic conjunctivitis. The generic drops are prescription medicines that are included in medical insurance catalogues in China and they will be available to consumers from China Sky One Medical in August 2009.
